Stock Events

Stock Events

Ainos Common Stock 

$1.4400
20
+$0.01+0.7% Friday 19:55
-$0.03-1.9%Friday 23:27After hours

Statistics

Day High
1.44
Day Low
1.44
52W High
4.25
52W Low
1.29
Volume
16
Avg. Volume
-
Mkt Cap
10.63M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.36
-0.91
-0.45
0
Expected EPS
N/A
Actual EPS
-0.57

Financials

-11,912.1%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
124,000Revenue
-14.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIMD. It's not an investment recommendation.
Coca-Cola
2
KO
Bitcoin
2
BTC.CRYPTO
Ethereum
2
ETH.CRYPTO
Palantir Technologies
2
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical company that competes with Ainos in the development and marketing of medications and therapies, including those in Ainos' focus areas.
Merck
MRK
Mkt Cap370.89B
Merck is a leading pharmaceutical company that develops medicines and vaccines, directly competing with Ainos in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its pharmaceutical segment, competes with Ainos in researching and developing healthcare solutions, including drugs and treatments.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie operates in the pharmaceuticals sector, focusing on immunology, oncology, and virology, areas that may overlap with Ainos' interests.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biotechnology company that competes with Ainos in the development of innovative therapeutics in various disease areas.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that compete with Ainos' product offerings.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences is a biopharmaceutical company that competes with Ainos in the development and commercialization of therapeutics in areas like infectious disease.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company that competes with Ainos in researching and developing innovative medicines in various therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that competes with Ainos in the pharmaceutical and diagnostics sectors, focusing on innovative treatments.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global biopharmaceutical company that competes with Ainos in the development and marketing of healthcare solutions across multiple therapeutic areas.

About

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
Show more...
CEO
Chun-Hsien Tsai
Employees
41
Country
United States
ISIN
US00902F1057
WKN
000A41AZJ

Listings

STU
DE
FZX0.STU
XNAS
US
AIMDW
XNAS
US
AIMD
F
DE
FZX0.F

0 Comments

Share your thoughts

FAQ

What is Ainos Common Stock stock price today?▼
The current price of AIMD is $1.44 USD — it has increased by +0.7% in the past 24 hours. Watch Ainos Common Stock stock price performance more closely on the chart.
What is Ainos Common Stock stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Ainos Common Stock stocks are traded under the ticker AIMD.
Is Ainos Common Stock stock price growing?▼
AIMD stock has fallen by -10% compared to the previous week, the month change is a -0% fall, over the last year Ainos Common Stock has showed a -59.55% decrease.
What is Ainos Common Stock market cap?▼
Today Ainos Common Stock has the market capitalization of 10.63M
What were Ainos Common Stock earnings last quarter?▼
AIMD earnings for the last quarter are -0.57 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ainos Common Stock revenue for the last year?▼
Ainos Common Stock revenue for the last year amounts to 124,000 USD.
What is Ainos Common Stock net income for the last year?▼
AIMD net income for the last year is -14.77M USD.
How many employees does Ainos Common Stock have?▼
As of September 13, 2026, the company has 41 employees.
In which sector is Ainos Common Stock located?▼
Ainos Common Stock operates in the Health & Wellness sector.
When did Ainos Common Stock complete a stock split?▼
The last stock split for Ainos Common Stock was on June 30, 2025 with a ratio of 1:5.
Where is Ainos Common Stock headquartered?▼
Ainos Common Stock is headquartered in HOUSTON, United States.